BioXcel Therapeutics, Inc. (BTAI)
1.20
-0.03
(-2.44%)
USD |
NASDAQ |
May 01, 16:00
1.19
-0.01
(-0.83%)
Pre-Market: 20:00
BioXcel Therapeutics EPS Diluted (Quarterly) : -1.028 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 13.54 |
| Puma Biotechnology, Inc. | 0.2608 |
| Quince Therapeutics, Inc. | -7.081 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.54M |
| Revenue (Quarterly) | 0.256M |
| Total Expenses (Quarterly) | 12.80M |
| Enterprise Value | 123.14M |
| Gross Profit Margin (Quarterly) | 58.59% |
| Profit Margin (Quarterly) | -4.90K% |
| Earnings Yield | -596.0% |
| Normalized Earnings Yield | -532.28 |